ArticleSurgical endoscopy2021
POEM: clinical outcomes beyond 5 years.
Article in Surgical endoscopy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.
- Long-term outcomes of peroral endoscopic myotomy for achalasia: a systematic review and meta-analysis with median follow-up ≥ 5 years.Surgical endoscopy · 2026Pooled it
- Mid-Term and Long-Term Outcomes of Peroral Endoscopic Myotomy for the Treatment of Achalasia: A Systematic Review and Meta-Analysis.Digestive diseases and sciences · 2023Pooled it
- Peroral endoscopic myotomyWorld journal of gastroenterology · 2022Trial
- Modern treatment for achalasia: endoscopic and surgical therapies.The British journal of surgery · 2026Review
- Per-oral endoscopic myotomy (POEM) results in improvement in an endoscopic score for achalasia (the CARS Score).Surgical endoscopy · 2026Article
- Management of Recurrent Dysphagia after POEM and Heller Myotomy: Current Strategies and Future Directions.Current gastroenterology reports · 2026Review
- Peroral endoscopic myotomy: a Danish single center 10-year follow-up study.Surgical endoscopy · 2025Article
- Epidemiology and practice patterns of achalasia in Taiwan: A nationwide population-based cohort study.Journal of the Chinese Medical Association : JCMA · 2025Article
- Clinical efficacy of peroral endoscopic myotomy treatment performed in patients diagnosed with achalasia.Northern clinics of Istanbul · 2025Article
- State-of-the-Art Surgery in Achalasia.Visceral medicine · 2024Review
- Long-term outcomes of treatment for achalasia: Laparoscopic Heller myotomy versus POEM.Annals of gastroenterological surgery · 2024Review
- Long-term efficacy of peroral endoscopic myotomy for achalasia under different criteria.Surgical endoscopy · 2024Article
- Peroral Endoscopic Myotomy for Achalasia in Older Adults: A Retrospective Analysis of 39 Cases with a Minimum Follow-Up of 5 Years.Dysphagia · 2023Article
- Probability of additional intervention and long-term follow-up of esophagomyotomy.Surgical endoscopy · 2023Article
- Peroral endoscopic myotomy for the treatment of achalasia in the Unified Healthcare System (SUS): results of a short-term.Revista do Colegio Brasileiro de Cirurgioes · 2023Article
- Submucosal endoscopy: the present and future.Clinical endoscopy · 2023Review
- Peroral Endoscopic Myotomy for Pediatric Achalasia: A Retrospective Analysis of 21 Cases With a Minimum Follow-Up of 5 Years.Frontiers in pediatrics · 2022Article
- POEM Is a Durable Treatment in Children and Adolescents With Achalasia Cardia.Frontiers in pediatrics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe short-term success of peroral endoscopic myotomy (POEM) is well documented but the durability of the operation is questioned. The aim of this study was to evaluate the clinical outcomes of the POEM procedure for esophageal motility disorders in a large cohort in which all patients had at least 5 years of follow-up.
methodsAll patients from a single center who underwent a POEM between October 2010 and September 2014 were followed for long-term clinical outcomes. Postoperative Eckardt symptom scores of short term and ≥ 5 years were collected through phone interview. Clinical success was defined as an Eckardt score < 3. Overall success was defined as Eckardt score < 3 and freedom from additional interventions.
resultsOf 138 patients, 100 patients were available for follow-up (mean age 56, 52% male). The indication for operation was achalasia in 94. The mean follow-up duration was 75 months (range: 60-106 months). Dysphagia was improved in 91% of patients. Long-term overall success was achieved in 79% of patients (80% of achalasia patients, 67% of DES patients). Preoperative mean Eckardt score was 6. At 6 months, it was 1, and at 75 months, it was 2 (p = 0.204). Five-year freedom from intervention was 96%. Overall, 7 patients had additional treatments: 1 balloon dilation (35 mm), 4 laparoscopic Heller myotomy, and 2 redo POEM at a mean of 51 months post-POEM. Ninety-three percent expressed complete satisfaction with POEM.
conclusionA multitude of studies has shown the early benefits of POEM. Here, we show that nearly 80% of patients report clinical success with no significant decrement in symptom scores between their short- and long-term follow-up. Clearly POEM is an effective option for achalasia with durable long-term treatment efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.